Inventor
LADNER ROBERT CHARLES
US54 patents
⚠️ This page may combine multiple inventors who share the name “LADNER ROBERT CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DYAX CORP
37 patentsUS6423498B1Jul 23, 2002
Variegated Kunitz domain peptide library and uses thereof
DYAX CORP143 citations99
US6333402B1Dec 25, 2001
Kallikrein-binding “Kunitz domain” proteins and analogues thereof
DYAX CORP115 citations99
US6057287AMay 2, 2000
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DYAX CORP125 citations99
US6010880AJan 4, 2000
Inhibitors of human plasmin derived from the kunitz domains
DYAX CORP102 citations99
US5994125ANov 30, 1999
Kallikrein-inhibiting "Kunitz Domain" proteins and analogues thereof
DYAX CORP112 citations99
US5795865AAug 18, 1998
Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
DYAX CORP145 citations99
US8044175B2Oct 25, 2011
Peptides that specifically bind HGF receptor (CMET) and uses thereof
DYAX CORP44 citations98
US7208293B2Apr 24, 2007
Directed evolution of novel binding proteins
DYAX CORP94 citations98
US7118879B2Oct 10, 2006
Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material
DYAX CORP80 citations98
US6979538B2Dec 27, 2005
Directed evolution of novel binding proteins
DYAX CORP80 citations98
US5663143ASep 2, 1997
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
DYAX CORP272 citations98
US6103499AAug 15, 2000
Inhibitors of human plasmin derived from the Kunitz domains
DYAX CORP79 citations97
US6071723AJun 6, 2000
Inhibitors of human plasmin derived from the Kunitz domains
DYAX CORP78 citations97
US5837500ANov 17, 1998
Directed evolution of novel binding proteins
DYAX CORP595 citations97
US6989369B2Jan 24, 2006
Kunitz domain peptides
DYAX CORP53 citations96
US6953674B2Oct 11, 2005
Inhibitors of human plasmin derived from the kunitz domains
DYAX CORP31 citations96
US9260520B2Feb 16, 2016
Antibodies to FeRn and uses thereof
DYAX CORP18 citations92
US7893007B2Feb 22, 2011
Directed evolution of novel binding proteins
DYAX CORP22 citations92
US7413537B2Aug 19, 2008
Directed evolution of disulfide-bonded micro-proteins
DYAX CORP40 citations92
US6326155B1Dec 4, 2001
Engineering affinity ligands for macromolecules
DYAX CORP42 citations90
US6084062AJul 4, 2000
Polypeptides that bind to tissue plasminogen activator (tPA)
DYAX CORP18 citations89
US7118872B2Oct 10, 2006
Binding polypeptides for B lymphocyte stimulator protein (BLyS)
DYAX CORP36 citations86
US10245307B2Apr 2, 2019
Prevention and reduction of blood loss
DYAX CORP3 citations84
US9757437B2Sep 12, 2017
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
DYAX CORP5 citations83
US9683028B2Jun 20, 2017
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
DYAX CORP5 citations79
US6906176B2Jun 14, 2005
Enterokinase cleavage sequences
DYAX CORP17 citations79
US10718066B2Jul 21, 2020
Libraries of genetic packages comprising novel HC CDR3 designs
DYAX CORP1 citations73
US10683342B2Jun 16, 2020
Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs
DYAX CORP2 citations73
US9562902B2Feb 7, 2017
Ligand screening and discovery
DYAX CORP2 citations73
US10829541B2Nov 10, 2020
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
DYAX CORP2 citations72
US10577598B2Mar 3, 2020
Display library process
DYAX CORP1 citations70
US9670481B2Jun 6, 2017
Display library process
DYAX CORP2 citations70
US9803190B2Oct 31, 2017
Focused libraries of genetic packages
DYAX CORP1 citations63
US6919424B2Jul 19, 2005
Binding peptides for carcinoembryonic antigen (CEA)
DYAX CORP4 citations58
US6774209B1Aug 10, 2004
Binding peptides for carcinoembryonic antigen (CEA)
DYAX CORP2 citations58
US10604753B2Mar 31, 2020
Focused libraries of genetic packages
DYAX CORP0 citations52
US9845340B2Dec 19, 2017
Peptides that specifically bind HGF receptor (cMet) and uses thereof
DYAX CORP0 citations52
LADNER ROBERT CHARLES
5 patentsUS8258082B2Sep 4, 2012
Focused libraries of genetic packages
LADNER ROBERT CHARLES69 citations97
US9617536B2Apr 11, 2017
Focused libraries of genetic packages
LADNER ROBERT CHARLES1 citations62
US8895475B2Nov 25, 2014
Focused libraries of genetic packages
LADNER ROBERT CHARLES1 citations62
US8466091B2Jun 18, 2013
Focused libraries of genetic packages
LADNER ROBERT CHARLES1 citations62
US8399384B2Mar 19, 2013
Focused libraries of genetic packages
LADNER ROBERT CHARLES2 citations62
TAKEDA PHARMACEUTICALS CO
4 patentsUS11926926B2Mar 12, 2024
Libraries of genetic packages comprising novel HC CDR3 designs
TAKEDA PHARMACEUTICALS CO0 citations63
US11598024B2Mar 7, 2023
Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs
TAKEDA PHARMACEUTICALS CO0 citations63
US11344610B2May 31, 2022
Prevention and reduction of blood loss
TAKEDA PHARMACEUTICALS CO0 citations62
US11479877B2Oct 25, 2022
Display library process
TAKEDA PHARMACEUTICALS CO0 citations60
TENHOOR CHRISTOPHER
2 patentsDRANSFIELD DANIEL T
1 patent(unassigned)
1 patentShowing the top 50 of 54 patents by PatentIndex Score.